In the News

1857 News Items found
Memorial Sloan Kettering prostate cancer surgeon James Eastham with colleague.
In the Clinic
Giving a two-drug combination before prostate cancer surgery appears to reduce the chance that some high-risk forms of the disease will come back.
Drawing of one human figure set apart from a group of others.
Finding
MSK researchers learn that some cancers may respond to checkpoint inhibitor drugs because of changes called gene fusions.
a cartoon of a cancer cell spooning glutamine from a jar
Feature
While sugar gets most of the attention as a cancer fuel, other nutrients can be equally important.
Three sets of PET images
Finding
MSK researchers are developing a new image-generation method for PET scans. It may prove to be quicker and clearer than current scans.
MSK President Craig Thompson
In a first-of-its-kind collaboration, MSK has joined forces with the Chinese Thoracic Oncology Group in an effort to establish a program of clinical trials that are open to patients from both the United States and China.
Ribbon diagram of an anthrax protein.
Science Byte
Researchers clarify how the immune system activates an inflammatory defense against pathogens.
In this fluorescent microscopy image of endoderm tissue from a mouse embryo, cell membranes are red, cell nuclei are blue, and extra-embryonic endoderm cells are green (they appear turquoise because blue and green are merged).
In the Lab
A large study that analyzed nearly 120,000 cells in a developing mouse embryo is full of surprises.
Cartoon of a hand offering cigarettes and another hand declining them.
Feature
Learn from MSK experts about how to quit smoking if you have cancer. It starts with having honest conversations about smoking and nicotine addiction.
Model of TGF-beta molecule
Feature
Drugs that block the action of TGF-ß may make checkpoint inhibitors more effective.
Close up photo of three pill types
Q&A
What's Become of AIDS-Related Cancers?
Several types of cancer were once strongly linked to an AIDS diagnosis. Thanks to improved HIV medications, that's changing.